In cancer cells metabolic changes and mitochondrial morphology are coupled. It is known that the cytoskeleton and molecular motors are directly involved in regulating mitochondrial morphology. Here we show that myosin-Va, an actin-based molecular motor, is required for the malignant properties of melanoma cells and localizes to mitochondria in these cells. Knockdown of myosin-Va increases cellular respiration rates and ROS production and decreases glucose uptake and lactate secretion. In addition, knockdown of myosin-Va results in reduced mitochondrial fission and correspondingly elongated mitochondria. We show that myosin-Va interacts with the mitochondrial outer membrane protein Spire1C, an actin-regulatory protein implicated in mitochondrial fission, and that Spire1C recruits myosin-Va to mitochondria. Finally, we show that during mitochondrial fission myosin-Va localization to mitochondria increases, and that myosin-Va localizes to mitochondrial fission sites immediately adjacent to Drp1 punctae. We conclude that myosin-Va facilitates mitochondrial fission. These data implicate myosin-Va as a target for the Warburg effect in melanoma cells.
INTRODUCTION
The reprogramming of cellular metabolism in favor of aerobic glycolysis is a hallmark of cancer, called the Warburg effect. In melanoma cells this is exemplified by the oncogenic mutation of BRAF V600E , which, among other changes, exacerbates mitochondrial fragmentation 4, 5 . Mitochondrial fusion and fission are coordinated by dynamin-related GTPase proteins, the endoplasmic reticulum (ER), and the actin cytoskeleton. Fission is mediated by DRP1 6 and DRP1 protein adaptors, such as Fis1 7, 8 . Fusion is mainly promoted by Mfn1 and Mfn2, acting on the outer mitochondrial membrane (OMM), and Opa1, on the inner mitochondrial membrane (IMM) 9 . However, growing evidence indicates that alterations of many protein players and pathways act to trigger mitochondrial fragmentation as an adaptive change in cancer cells, in a process not completely understood.
Myosin-Va plays a central role in the transport of melanosomes in melanocytes, but a widespread subcellular distribution and other lines of evidence have paved the view that it has a much wider function. For instance, myosin-Va is concentrated in microtubule-rich domains 10, 11 , associates with nuclear speckles 12 , and with the majority of cytoplasmic organelles, including the ER, Golgi, endosomes, peroxisomes, and mitochondria 13, 14 .
Myosin-Va is also upregulated in metastatic melanoma cells and required for manifestation of malignant properties, such as anchorage independent survival, migration, and invasion 15 . In addition, by sequestering the pro-apoptotic factor Bmf 16 , myosin-Va modulates apoptosis triggered by mitochondrial outer membrane permeabilization (MOMP). Interfering in this pathway by overexpressing a small fragment of the myosin-Va tail, which encompasses the DYNLL2 binding site, induces apoptosis in melanoma cells 1 . The myosin-Va ortholog, Myo2p, is required for mitochondrial transport and mitochondrial inheritance in daughter cells in the budding yeast Saccharomyces cerevisiae 17 . In mammalian cells, myosin-Va knockdown has also been shown to increase mitochondrial size in neurons 18 , as well as mediate energy metabolism via GLUT4 translocation in adipocytes and muscle cells [19] [20] [21] .
The processes of mitochondrial fusion and fission are intertwined with the nutritional and metabolic status of the cell. Many layers of structural and regulatory components influence the fusion and fission effectors, including the cytoskeleton and molecular motors 2, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . Several studies have shown that myosin-V motors interact with and are recruited by the actin nucleating proteins Spire to Rab11-decorated membrane vesicles [32] [33] [34] [35] . Recently, the Spire1C isoform that is anchored to the OMM was shown to modulate mitochondrial fission 2 .
In view of this and other lines of evidence mentioned above, we postulated that myosin-Va may play a role in mitochondrial dynamics. To investigate this, we examined the effects of depleting myosin-Va on mitochondrial function, morphology and structural integrity in the A375 BRAF V600E mutant metastatic melanoma cell line. We found that myosin-Va depletion in A375 BRAF V600E cells causes increased ROS production, lower mtDNA levels, and mitochondrial elongation. We also show that Spire1C interacts with the myosin-Va tail, and that increased expression of Spire1C recruits myosin-Va to the mitochondrial outer membrane. In addition, we found that myosin-Va localizes to mitochondrial fission sites adjacent to Drp1. Our results reveal a role for myosin-Va in mitochondrial fission, further increasing our understanding of the molecular crosstalk between myosin Va, the actin cytoskeleton, and mitochondrial dynamics.
RESULTS

Myosin-Va knockdown increases melanoma cell OXPHOS activity while leading to decreased clonogenic ability
To investigate whether myosin-Va plays a role in the mitochondrial function and melanoma cell metabolism, we knocked down MYO5A in A375 BRAF V600E mutant cells, using two short hairpin RNAs to human myosin-Va (shMVa1, shMVa2) with 60-85% efficiency ( Figure 1A and 1B) , and a non-targeted shRNA as control (shCTRL).
First, we analyzed oxygen consumption of the cells, and found that myosin-Va knockdown cells displayed increased oxygen consumption rates on basal, State III (phosphorylation state -OXPHOS capacity), proton leak (L) and maximal respiratory capacity (E -mitochondrial electron transfer system) states ( Figure 1C -G) 36 . We also analyzed the clonogenic ability of these cells, and we found that myosin-Va knockdown cells had lower clonogenic capacity compared to control cells ( Figure 1H ). Accordingly, myosin-Va knockdown cells showed lower uptake of glucose, lower lactate secretion, and higher ROS production than control cells ( Figure 1I -K). To understand if the alterations in mitochondrial function affected the expression of genes and their respective protein products involved in mitochondrial biogenesis and dynamics, we performed mRNA and protein expression analysis. DRP1 mRNA and Drp1 proteins, both total Drp1 and p(S616)Drp1, were unchanged ( Figure   S1A -C). Mfn1 and Mfn2 mRNA levels were slightly decreased, but no alteration in protein levels were observed ( Figure Figure S1A Knockdown of myosin-Va in A375 cells increases oxidative phosphorylation, increases ROS production, and lowers the glucose uptake levels and lactate secretion levels. (A) MYO5A mRNA expression in A375 cells stably transduced with two different shRNAs (shMVa1 and shMVa2). The values plotted are relative to shCTRL. The GAPDH gene was used as housekeeping with the formula 2-ΔΔCt to normalize the expression level. Data are mean ±SD (n=3), **** P< 0.0001. (B) Western blots containing total lysate of transduced A375 cells (line 1-shCTRL; line 2-shMVa1 and line 3-shMVa2) probed with affinity-purified rabbit polyclonal antibody raised to bacterially-expressed GST-myosin-Va medial tail (MVa) and a commercially-available monoclonal antibody to ɣ-Tubulin (ɣ-Tub) used as protein load normalizer. The densitometry quantification of myosin-Va relative to ɣ-Tubulin is shown below. Data are mean ±SD (n=3), **** P< 0.0001. (C) Mitochondrial respiratory parameters of A375 mysoin-Va knockdown cells (shMVa1 and shMVa2) and control (shCTRL)-Representative oxygraph traces of showing respiratory activity of digitoninpermeabilized cells in the presence of substrate for complex I (pyruvate, glutamate and malate). Arrows indicate the additions of 240 μM ADP, 0.5 μg/mL oligomycin (oligo), 0.25 μM CCCP and 0.5 μg/mL antimycin A (AA) used to determine the States of Basal, State III or phosphorylating (P), proton leak (L), maximal respiratory capacity (E) and residual (Rox). (D) Respiratory rates in States Basal, (E) State II, (F) Proton leak, and (G) maximal respiratory capacity. The values represent the mean ± S.E.M from five independent experiments (one 100cm dish plate was used for each experiment, approximately 1x106 cells). One-way ANOVA test followed by post hoc Turkey test was used for data analysis. *P<0.05. (H) Clonogenic assay showing a representative figure of the colonies for A375 myosin-Va knockdown cells and control, and quantification of the number of colonies for each cell. The values represent the mean ± S.D. from three independent experiments. One-way ANOVA test followed by post hoc Dunnet test was used for data analysis. ***P<0.0005; ****P<0.0001. (I) Glucose uptake quantification, (J) Lactate secretion quantification, and (K) ROS production quantification in A375 myosin-Va knockdown and control cells. The values represent the mean ± S.D from three independent experiments. One-way ANOVA test followed by post hoc Dunnet test was used for data analysis. *P<0.01; **P<0.001 OPA1 mRNA expression was increased, but no alteration of OPA1 protein levels were detected ( Fig Figure S1A -C). We also observed an increase in the mRNA levels for PGC1α, a master regulator of mitochondrial biogenesis ( Figure S1D ). Additionally, myosin-Va knockdown cells had decreased levels of mtDNA ( Figure S1E ).
Myosin-Va depletion reduces mitochondrial fission and leads to mitochondrial elongation
A375 BRAF V600E mutant cells possess predominantly fragmented mitochondria, which makes them a useful model for understanding changes in mitochondrial dynamics. To investigate whether knockdown of myosin-Va alters mitochondria in these cells, we imaged myosin-Va knockdown (shMVa2) versus control (shCTRL) cells. We found that knockdown cells displayed longer mitochondria ( Figure 2A ). Over 40% of the knockdown cells showed elongated mitochondria, whereas only 12% of shCTRL cells showed elongated mitochondria.
Consistently, the frequency of cells with fragmented mitochondria was above 70% in shCTRL cells and only about 30% in the myosin-Va-knockdown cells ( Figure 2B ).
Finally, using live timelapse imaging of shMVa2 vs shCTRL cells stained with mitotracker, we found that myosin-Va knockdown cells displayed a reduced number of mitochondrial fission events ( Figure 2C and Suppl. Movie 1+2).
To better understand the morphological changes in knockdown cells, we employed transmission electron microscopy (TEM). TEM imaging revealed the presence of enlarged mitochondria in the myosin-Va knockdown cells in comparison to shCTRL cells ( Figure 3A ). Quantification of area ( Figure 3B ) and perimeter ( Figure 3C) confirmed mitochondrial enlargement in knockdown cells. Interestingly, the length of contact regions between endoplasmic reticulum and the mitochondrial surface relative to the total length of the mitochondrial perimeter also decreased in the knockdown cells ( Figure 3D ). showing the mitochondrial network immunostained with anti-TOMM20 (yellow) antibody, the F-actin were stained with phalloidin-Alexa-594 (magenta) and the nuclei with DAPI (cian). (B) The mitochondrial morphology was quantified by classifying the appearance of mitochondria in A375 myosin-Va knockdown cells; at least 150 cells were counted on three different slides. (C) Number of fission events of myosin-Va knockdown cells (shMVa2) compared to control cells (shCTRL), representative movies are shown in supplementary material. Data was analyzed using Unpaired t test, ****P<0.0001 (n=10 cells for each condition). Scale Bar: 10μm and 1µm in the insets. Data are mean ±SD. **P < 0.001. Figure S2A) and, by examining the orthogonal projection, we observed that myosin-Va clusters often surround the mitochondrial network ( Figure S2B and S2C). This colocalization was not due to randomly colocalized pixels, since when we rotated the image of myosin-Va staining 180° relative to the TOMM20 image and reanalyzed 37 , the Pearson's correlation coefficient was then as low as 0.005±0.06. Similar colocalization was obtained using rabbit anti-myosin-Va and anti-Cytc co-staining ( Figure 4A ). Also, structured illumination microscopy showed that myosin-Va localizes to discrete clusters associated with TOMM20 stained mitochondria ( Figure 4B ). The degree of colocalization seen here is consistent with the one previously observed by our group in melanoma cells using immunogold staining 38 . 
Myosin-Va localizes to discrete clusters on the mitochondrial surface
Myosin-Va interacts with and is recruited by Spire1C to mitochondria
We performed affinity chromatography with the medial-globular tail domain of myosin-Va (MVa-MGT) and the cargo binding domain of myosin-VI to identify potential novel binding partners for those proteins. Samples were analyzed using mass spectrometry, and the candidate binding proteins were sorted according to 39 compared to the non-mitochondrial isoform (Spire1DC) ( Figure 5B ). To further test whether there is an interaction between Spire1C and the myosin-Va tail, we used a rabbit reticulocyte system for in vitro translation of myc-tagged Spire1C and a myosin-Va tail fragment containing the medial and globular domains. Using this assay, we showed that Spire 1C co-purifies with the myosin-Va tail ( Figure 5C ).
To test the hypothesis that myosin-Va is shown below, and it was used for the in vitro interaction with Spire1 proteins. Full length Spire1C domain structure is shown, with the subdomains also represented, KIND, WH2 and ExonC. we overexpressed myc-Spire1C and GFP-tagged chicken myosin-Va tail fragments (full tail; medial-globular tail; globular tail) in mammalian A375 cells ( Figure 6 ). We found that all GFP-tagged myosin-Va tail constructs used ( Figure 6 ), but not the GFP tag alone ( Figure S3A ), localizes to mitochondria much more strongly in cells overexpressing myc-Spire1C than in control cells ( Figure 6 ; Figure S3B -E). These results support the hypothesis that Spire1C recruits myosin-Va to the OMM by interacting with the myosin-Va tail domain.
Myosin-Va is located at mitochondrial fission sites along with Drp1
To better understand the potential role of myosin-Va in mitochondrial fission, we co-expressed the full length GFP-myosin-Va with a mitochondrial marker in U2OS cells and used high resolution Airyscan timelapse imaging to monitor mitochondrial dynamics (Figure 7 , Suppl.
Movie 3 and Movie 4). We found that 58% of the fission events counted had myosin-Va accumulation ( Figure 7C ), often at the tips of "daughter" mitochondria ( Figure 7A and 7B). We also induced fission by treating the cells with ionomycin and observed a significant increase in fission events containing myosin-Va (in ~74% of fission events counted) ( Figure 7B and 7C). To confirm the role of endogenous myosin-Va in the fission events, we co-stained U2OS cells with anti-myosin-Va, anti-Drp1, and anti-HSP60. We observed a significant fraction of myosin-Va localized to mitochondrial constriction sites, often adjacent to Drp1 at the ends of "daughter" mitochondria, suggesting that while these two proteins may not directly interact, they may both be localizing to active fission sites ( Figure 8A ). To further test the putative role of myosin-Va in fission, we induced fission by treating cells with ionomycin, then stained for myosin-Va, Drp1, and HSP60. As expected, Drp1 localization to mitochondria significantly increased by ~1.4x (from 43.5% to 60.6%) in cells treated with ionomycin ( Figure 8C ). In support of our hypothesis that myosin-Va plays a role in mitochondrial fission, myosin-Va localization to mitochondria increased by ~1.3x (from 37.3% to 48.3%) in ionomycin treated cells ( Figure 8D ).
High magnification views of mitochondrial constriction sites revealed a high frequency of myosin-Va and Drp1
puncta localized at fission sites ( Figure 8B ). Interestingly, our affinity chromatography results also identified Drp1 as a candidate binding protein for myosin-Va, also with specificity for myosin-Va over myosin-VI (Suppl. Quantification of fission events that myosin-Va was present, either in the constriction of the mitochondria and in the tips of newly formed mitochondria. Fission events were counted from at least 5 timelapses for each condition. Unpaired t test was used for the analysis, data are mean ± SD, **P < 0.001. Scale Bar: 1μm
DISCUSSION
Oncogenic transformation by expression of BRAF V600E , the most frequent oncogenic driver in melanoma, typically leads to metabolic reprogramming that favors aerobic glycolysis in detriment of OXPHOS, the Warburg effect 40, 41 . This metabolic reprogramming of cancer cells is accompanied by mitochondrial fragmentation, which is likely linked to changes in their activity [42] [43] [44] . The human metastatic melanoma cell line A375 harbors a BRAF V600E mutation and possesses predominantly fragmented mitochondria, which makes them a useful model for understanding mitochondrial dynamics in the context of cancer 5, 40 . It is also worth underscoring that melanoma cells exhibit relatively high MYO5A gene expression 15 , thus provide a unique opportunity for studying MYO5A functions. Our data show that myosin-Va knockdown in A375 cells leads to higher rates of mitochondrial respiration, lower glucose consumption and lactate secretion, and higher ROS production. Such alterations are accompanied by reduced mitochondrial fission, culminating in mitochondrial elongation. These data support the conclusion that the morphological alterations triggered by loss of myosin-Va function perturb the Warburg effect caused by MAPK pathway activation in melanoma cells. It is now widely known that the Warburg effect favors biomass building of proliferative tissues 45 . Therefore, the reduced clonogenic ability of myosin-Va knockdown cells is consistent with our metabolic data and corroborates previous findings 1, 15 . Exploring the possibility that myosin-Va functions as an effector molecule of the MAPK pathway to enhance mitochondrial fragmentation induced by oncogenic transformation is an intriguing possibility worthy of further exploration.
However, the scope of the present study was directed toward understanding the mechanistic role of myosin-Va on the fission process itself, and a major finding was the demonstration that myosin-Va molecular motors interact with Spire1C through their tail domain and are recruited by Spire1C to the OMM. Moreover, myosin-Va localizes to mitochondrial fission sites, adjacent to Drp1, and its knockdown reduces Drp1 and pDrp1 localization to the mitochondria.
The mitochondrial elongation triggered by myosin-Va knockdown in A375 melanoma cells is consistent with previously reported increase in mitochondrial size following knockdown of myosin-Va in neurons 18 . The diminished number of fission events observed in A375 melanoma cells is consistent to a role of myosin-Va in mitochondrial fission, as it has been widely shown that a deficiency in the fission process results in mitochondrial elongation upon inactivation of key proteins of the fission machinery, such as myosin II 26 Given the results in our ionomycin experiments, it is interesting to consider that myosin-Va activity is calciumdependent 38, 48, 49 . Among other mechanisms, it has been shown that myosin-Va associates to the ER and binds to the ryanodine calcium receptor channels on the ER membrane, and also responds to ER-derived calcium by associating with vesicles and directing them to specific sites 50 . More recently, myosin-Va was shown to tether synaptic vesicles to the plasma membrane near Ca +2 influx sites and help to increase the retention of vesicles at the release site 51 . The decrease in the ER-mitochondrial contact surface, observed here in myosin-Va knockdown cells, is also consistent with a calcium triggered-role for myosin-Va at the ER-mitochondrial interface. Taken together, these findings suggest myosin-Va helps regulate mitochondrial fission by responding to local cytoplasmic calcium. This is a tempting hypothesis, as calcium can also increase actin polymerization and mitochondrial fission 52, 53 .
Although we have not yet elucidated the biophysical mechanisms underlying mitochondrial elongation triggered by loss of myosin-Va, our data are indicative of a decreased number of fission events in the knockdown cells.
The diminished extent of Drp1 localization to mitochondria in knockdown cells, and the localization of myosin-Va to fission sites in normal cells implicates myosin-Va as an enhancing factor for mitochondrial fission. Indeed, myosin-Va is an actin-based molecular motor, and as shown previously by multiple studies, actin and the ER are essential for Drp1-mediated mitochondrial fission 2,24-29,53,54 . Moreover, as Drp1 is as a candidate binding protein for myosin-Va, an interaction between those proteins could be a mechanistic explanation for the myosin-Va role in mitochondrial fission. In addition to Drp1, we postulate that other GTPase molecules are probably involved in myosin-Va mediated fission, given previous evidence that Rab7a and Rab11a can interact with and activate mitochondrial fission machinery 55, 56 . Interestingly, Spire family proteins interact with both myosin-Va and Rab11a to regulate vesicle motility, suggesting a conserved molecular mechanism by which myosin-Va, Rab
GTPase proteins, and actin regulatory proteins cooperate to regulate membrane-bound organelle dynamics.
Furthermore, previous studies have shown a role for myosin-Va in regulating ER dynamics 57 , providing one more potential mechanistic link between myosin-Va activity and mitochondrial fission. That myosin-Va is a motor protein specialized for directed motility and transport, along with the localization of myosin-Va at the separating ends of daughter mitochondria, suggests that myosin-Va may play a role in moving newly separated mitochondria apart to complete the fission process and/or to avoid that they fuse back. Concluding, the results presented here prompt many questions to be pursued in future studies regarding the molecular partners of myosin-Va that are required to promote the fission process, and how its function is regulated, both in normal and cancer cells.
MATERIALS AND METHODS
Cell culture
Cell 
Lentivirus production and cell transduction
For lentiviral production, HEK-293T cells were cultured in suitable medium and transfected by calcium phosphate method with the following plasmids: 10 μg of pLKO.1 (Sigma-Aldrich, St Louis, MO, USA -SHCLNG-NM_000259), containing the shRNA cassette; 3.5 μg pVSV-G, 6.5 μg pΔ8.9, with culture medium with serum and without antibiotic. After sixteen hours, the transfection medium was changed to complete culture medium.
Collection of the supernatant was performed on day 2 or 3 post-transfection. The supernatant was filtered through a 0.22 μm membrane and added to the cells of interest for the transduction. After 48 hours, the culture medium was changed to 10% DMEM medium containing puromycin (1 μg/ml) for selection of transduced cells.
The sequences of the shRNA used here are in Table 1 . according to the manufacturer's specifications. gDNA was amplified using primers according to a method previously described 58 . The sequences analyzed are in Table 1 . Relative quantification of mtDNA expression was performed using the 2-ΔΔCt method, and normalized with nDNA.
Total RNA was extracted from the cells using the TRIZOL reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's specifications. The RNA pellets were suspended in DEPC water and the samples were quantified at 260/280 nm in a spectrophotometer (NanoVue -GE Life Sciences, Buckinghamshire, England). (Table   15 2). The real-time PCR data were analyzed using the unpaired t-test, with P<0.05 considered statistically significant. Table 2 . Sequences of the primers used for qRT-PCR.
Gene Sequence
Forward Myosin Va 5'-CCTTTCAACCCATCTTCCCCT-3'
Reverse Myosin Va 5'-TTGCCTGGACATCACTTTCA-3'
Reverse MFN1 
Exogenous protein overexpression
For exogenous protein overexpression assays, 5 × 10 4 A375 cells were incubated overnight on 13 mm diameter cover slips (Knittel, Braunschweig, Germany) in 24-well plates (Corning incorporated Costar ® ). The cells were transfected using Lipofectamine ® 2000 (Thermo Fisher Scientific, Carlsbad, CA). Transfections were carried out in a final volume of 250μL medium following the manufactures' instructions. After 48h of incubation, cells were washed with PBS, fixed with 4% (v/v) paraformaldehyde pH 7.4 for 15 min, washed once more with PBS and processed for immunofluorescence and data acquisition as described above. For these assays, cells were imaged using a Leica CTR 6000 microscope (Leica).
The following constructions were used: mCherry-DRP1 (AddGene Plasmid #49152); pDsRed-Mito (AddGene Plasmid #55838); full length Spire1C (myc-SpireFL) 2 ; mouse myosin-Va-Full Length (MyoVaFL-GFP) 59 ; chicken brain globular tail of myosin-Va (GT-GFP -residues 1423-1830); chicken brain medial tail (partial) and globular tail of myosin-Va (MGT-GFP -resiidues 1377-1830); chicken brain full tail of myosin-Va (FT-GFP -residues 899 -1830) ( Figure S4 for a schematic of the constructs).
Immunocytochemistry
Cells (6.0x10 4 ) were grown in 24 wells plates on coverslips in appropriate culture medium, as described above. 
Structured Illumination Microscopy (SR-SIM)
The immunofluorescence stained cells were subjected to SR-SIM in an ELYRA S.1 microscope (Carl Zeiss Microimaging), equipped with a 488-nm laser (100 mW), a 561-nm laser (100 mW) and an Andor EM-CCD camera (iXon DU 885). Thin (0·1 mm) Z-stacks of high-resolution image frames were collected in 5 rotations by utilizing an alpha Plan-Apochromat 63×/1·46 oil DIC M27ELYRA objective. Image acquisition, reconstruction, and alignment for structured illumination microscopy were performed using the Zeiss ZEN 2012 SP1 software (black edition, version 8.1.5.484), as previously described 62 .
Transmission electron microscopy (TEM)
Cells (2.0x10 5 ) were grown in a 6-well plate in appropriate cell medium as described above. After 18-24h cells were fixed with 2% glutaraldehyde, 2% formaldehyde, 0,5% CaCl 2 in PBS with Ca +2 and Mg +2 for 2 hours at 37°C.
Then cells were washed with 0.1M cacodylate buffer (pH 7.4) for 1h at 4°C. The fixed cells were post-fixed with 1% OsO 4 for 2 hours at 4°C, washed with H 2 O, and dehydrated in a graded series of ethanol (30% to 100%), infiltrated with propylene oxide and embedded in Embed 812 resin, polymerized for 72 hours at 60°C. Thin sections were stained with uranyl acetate and lead citrate for 10min and examined with an electron microscope (Jeol JEM-100 CXII). A unique experiment with two grades were analyzed.
Metabolite Detection Assays
ROS-Glo™ H 2 O 2 assay (Promega cat. #G8820) was used to the level of hydrogen peroxide (H₂O₂) produced by the cells. For this, 10,000 cells were plated on 96-well plates the day before the experiment. To perform the assay, H 2 O 2 was added for 4 hours, and the manufacturer's recommendations were followed.
Glucose Uptake-Glo™ assay (Promega cat. #J1341) was used to measure the glucose uptake in the cell culture.
For this, 20,000 cells were plated on 96-well plates the day before the experiment, and the manufacturer's recommendations followed.
Lactate secretion was measured in cell media of cultured cells using the Lactate-Glo™ assay (Promega cat. # J5021). For this, 50,000 cells were plated on 24-well plates, media was collected 48h after, and the manufacturer's recommendations were followed.
Clonogenic assay
300 cells were transferred to 6 well plates and maintained for 10 days in a cell incubator under 95% air and 5% CO2 at 37 °C. After this period, the cells were fixed with 4% paraformaldehyde (w/v) in PBS (pH 7.4) and stained with 2% violet crystal (w/v) in 0.2% ethanol (v/v) for visualization of the colonies. The dishes were photographed and the colonies number were counted.
Respiratory rates
Oxygen consumption was monitored using a High-Resolution Respirometer (OROBOROS Oxygraph) equipped with DatLab 5.0 (Oroboros, Innsbruk, Austria). Cells were cultured in 100mm dishes, the FBS was removed 24h prior the experiment. In the day of the experiment, the cells were detached and counted 1x10 6 cells for each condition, that were incubated in 2 mL air saturated MiR05 respiration buffer (20 mM HEPES, 10 mM KH2PO4, 110 mM sucrose, 20 mM taurine, 60 mM K-lactobionate, 0.5 mM EGTA, 3 mM MgCl2, 1 g/L fatty acid-free BSA, 
Myosin-Va affinity chromatography and cloning of candidate genes
Performed by R. Taranath and M. Stern according to the methods of Finan, Hartman and Spudich with the following modifications 39 . Briefly, the melanocyte isoform (Roland et al., 2009) of mouse myosin-Va globular tail domain containing some of the coiled-coil region (to aid in dimerization and stability) was purified and used to construct an affinity column according to previous protocols 39 . The cargo binding domain of myosin-VI was used as a comparison and internal control. Brain extract from 6-8 week-old BL6 mice was flowed onto the column, and proteins were eluted with increasing salt washes. Proteins and protein complexes binding most tightly to the MVa column were eluted with 1M KCl, and analyzed using SDS-PAGE and mass spectrometry.
Confirmation of binding of Spire1C to myosin-Va
Direct binding assays were performed according to Finan, Hartman, and Spudich 39 . Briefly, a myc-Spire1C construct lacking the N-terminal KIND domain was translated in vitro using rabbit reticulocyte lysates. Binding reactions were performed by combining translated myc-Spire1C products with purified myosin-Va or myosin-VI tail domains attached to glutathione-agarose; myosin VI was used as a control for non-specific binding. Proteins co-purifying with myosin-Va or myosin-VI were isolated and analyzed with immunoblots. An HRP-conjugated mouse anti-myc antibody (Abcam) was used at 1:10000 prior to developing the blot with the SuperSignal West Pico Chemiluminescent Substrate kit (Pierce).
Spire1C immunoprecipitation
Myc-tagged Spire1C full-length and ∆ExonC constructs (or empty pcDNA3.1(+) vector) were transfected into a 10-cm dish of HEK293T cells using Lipofectamine 2000 according to manufacturer's protocol. 48 hours posttransfection, cells were harvested and lysed in RIPA buffer (Thermo #89901) supplemented with Roche complete protease inhibitor cocktail tablet and 1 mM PMSF. Cells were lysed on ice for 20 min followed by centrifugation at 20,000×g for 20 min at 4°C to remove cell debris. Cell lysates were incubated with myc-tag antibody (Cell Signaling 2276S) at 4°C overnight. The next morning, pre-washed protein A/G agarose beads (Santa Cruz Biotechnology, sc-2003) were added and rotated at 4°C for 2 hours. Bound proteins were washed four times with 1×TBST and eluted with 1×SDS loading dye. The eluents were then processed for proteomics.
Mass Spectrometry and Data Analysis
The digested samples were analyzed on a Q Exactive mass spectrometer (Thermo). The digest was injected directly onto a 30 cm, 75 µm ID column packed with BEH 1.7 µm C18 resin (Waters). Samples were separated at a flow rate of 200 nl/min on a nLC 1000 (Thermo). Buffer A and B were 0.1% formic acid in water and acetonitrile, respectively. A gradient of 5-40% B over 110 min, an increase to 50% B over 10min, an increase to 90% B over another 10min and held at 90% B for a final 10 min of washing was used for 140 min total run time. Column was re-equilibrated with 20 µl of buffer A prior to the injection of sample. Peptides were eluted directly from the tip of the column and nanosprayed directly into the mass spectrometer by application of 2.5 kV voltage at the back of the column. The Q Exactive was operated in a data dependent mode. Full MS 63 scans were collected in the Orbitrap at 70K resolution with a mass range of 400 to 1800 m/z and an AGC target of 5e 6 . The ten most abundant ions per scan were selected for MS/MS analysis with HCD fragmentation of 25NCE, an AGC target of 5e 6 and minimum intensity of 4e 3 . Maximum fill times were set to 60 ms and 120 ms for MS and MS/MS scans respectively. Quadrupole isolation of 2.0 m/z was used, dynamic exclusion was set to 15 sec and unassigned charge states were excluded.
Protein and peptide identification were done with Integrated Proteomics Pipeline -IP2 (Integrated Proteomics Applications). Tandem mass spectra were extracted from raw files using RawConverter 63 and searched with ProLuCID 64 against human UniProt database. The search space included all fully-tryptic and half-tryptic peptide candidates with maximum of two missed cleavages. Carbamidomethylation on cysteine was counted as a static modification. Data was searched with 50 ppm precursor ion tolerance and 50 ppm fragment ion tolerance. Data was filtered to 10 ppm precursor ion tolerance post search. Identified proteins were filtered using DTASelect 65 and utilizing a target-decoy database search strategy to control the false discovery rate to 1% at the protein level.
Acquisition, processing and analysis of confocal images
Confocal images were collected using Leica SP5 or Leica SP8 confocal microscopes, with a oil 63x 1.4NA oil immersion objective. When indicated, the images were imaged with a 63x 1.4NA oil objective on a ZEISS 880 LSM Airyscan confocal system with an inverted stage and heated incubation system with 5% CO2 control, also used for the timelapses. The images were processed and analyzed using Icy-Bioimage and NIH-developed Image 
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